Add BrightSurf on Google Email

JCI Journals


The neurobiology behind why eating feels so good

Researchers have found that ghrelin stimulates the same pleasure and reward neurons as food, sex, and drugs, leading to increased food intake. Ghrelin binds to receptors in the brain's ventral tegmental area (VTA), triggering dopamine production.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 19, 2006

JCI table of contents: October 19, 2006

Two studies published in the Journal of Clinical Investigation reveal key roles for PLC-gamma-2 and NF-kappa-B in immune responses. PLC-gamma-2 regulates osteoclast development and B cell differentiation, while NF-kappa-B controls endothelial cell function in models of sepsis and cancer.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 19, 2006

JCI table of contents: Oct. 12, 2006

Researchers discovered that caveolin-3 inhibits myostatin signaling, preventing muscle wasting. Additionally, elevated PTTG1 levels triggered mitotic mischief, causing aneuploidy in thyroid cancer cells. Understanding these mechanisms can lead to potential therapies for muscular dystrophy and thyroid cancer.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 12, 2006

JCI table of contents: Oct. 5, 2006

Researchers discover RELM-beta's role in IBD, finding it activates macrophages to produce pro-inflammatory factors. Additionally, antibodies against BP180 cause blister formation in mice by activating the classical complement pathway.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 5, 2006

JCI table of contents: Oct. 2, 2006

Researchers at University of Texas Medical School identified proteins required for E. faecalis endocarditis, potentially leading to new treatment approaches. In another study, tumors induce immunosuppressive inflammatory monocytes that can blunt the anti-tumor immune response, providing new avenues for cancer therapy development.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 2, 2006

JCI table of contents: September 21, 2006

Researchers have identified calcineurin as essential for complete lung development, and its absence led to respiratory problems in mice. A new model of human placental development also sheds light on the complex process of placentation, while a study on thyroid structures reveals that mature T cells trigger their formation.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 21, 2006

Calcineurin helps newborns breathe easy

In a study published in JCI Journals, researchers found that calcineurin is essential for complete lung development in mice. Mice lacking calcineurin function died shortly after birth due to lung failure.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 21, 2006

JCI table of contents: September 14, 2006

Researchers found that imatinib can block the development of disease in a mouse model of rheumatoid arthritis, providing hope for a new treatment. Additionally, studying adrenomedullin's effect on female mice revealed that reduced expression may severely decrease fertility. Meanwhile, a study on TNF-alpha discovered that it decreases e...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 14, 2006

AM: A gene that affects female fertility

A study by Kathleen Caron and colleagues found that reduced expression of gene AM in female mice leads to severely decreased fertility and fetal growth issues. This suggests a potential link between altered AM expression in humans and impaired fertility.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 14, 2006

Can Gleevec help patients with rheumatoid arthritis?

Researchers at Stanford University have found that Gleevec can block the development of disease in a mouse model of rheumatoid arthritis, providing hope for a new treatment. Imatinib inhibits the function of immune cells contributing to RA and also suppresses joint cell proliferation.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 14, 2006

PNP gets a pass to enter cells

Scientists have found a way to get purine nucleoside phosphorylase (PNP) into the cells of mice lacking the enzyme, which could lead to a treatment for individuals with PNP deficiency. The PTD-PNP fusion protein corrected most immune defects in Pnp-deficient mice.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 7, 2006

JCI table of contents: September 7, 2006

Scientists develop method to introduce purine nucleoside phosphorylase (PNP) enzyme into cells of mice with genetic defect, potentially leading to treatment for individuals lacking PNP. Research also sheds light on scavenger receptor BI's role in protecting against heart disease.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 7, 2006

Estrens might not be the answer for osteoporosis

A new study questions the use of estrens as estrogen-like molecules for treating osteoporosis. Estrens improved bone strength in mice, but also caused adverse effects on reproductive organs and human breast cancer cells. Further clinical trials are needed to determine their safety.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 1, 2006

JCI table of contents: September 1, 2006

Researchers found that estrens improved bone strength in mice with osteoporosis but also had adverse effects on reproductive organs and human breast cancer cells. This study suggests caution is needed for the development of estrens as a treatment for osteoporosis.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 1, 2006

An irregular heartbeat makes exercise deadly

A lack of cardiac calsequestrin protein can cause irregular heartbeats during exercise, but not at rest. Researchers found that the protein's absence triggers premature calcium release, leading to life-threatening conditions like CPVT.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 24, 2006

JCI table of contents: August 24, 2006

Researchers have made significant breakthroughs in cancer vaccine development and cardiac health. A study on mice vaccinated with mimotopes inducing intermediate magnitude T cell responses found protection against tumor growth, while a study on Casq2-deficient mice revealed the mechanisms behind irregular heartbeats during exercise.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 24, 2006

JCI table of contents: August 17, 2006

Researchers discovered that phosphatase and tensin homolog (PTEN) regulates the proliferative capabilities of naturally occurring CD4+CD25+ Tregs but not their suppressive function. This finding provides a potential solution to harnessing the therapeutic potential of Tregs in autoimmune diseases.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 17, 2006

PTEN: the Treg's handbrake

Researchers identified PTEN as a key regulator of Treg responsiveness to IL-2, enabling their proliferation and maintaining suppressive function. This discovery could provide a way to overcome the major challenge of harnessing Tregs for autoimmune disease treatment.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 17, 2006

Protein plays broader role than originally thought in neurofibromatosis

Researchers found that restoring Ras-GAP activity through expression of the human NF1 GAP-related domain restored normal cardiac development in mice with Neurofibromatosis type I disease. However, this approach did not fully restore all pathologies associated with neurofibromin loss, indicating a more complex role for the protein.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 10, 2006

JCI table of contents: August 10, 2006

In a study, researchers found that modulation of Ras activity is not the only function of neurofibromin, suggesting alternative therapeutic approaches for Neurofibromatosis type I disease. Interferon-gamma also plays a critical role in maintaining immune response balance by inducing Foxp3 and converting T cells.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 10, 2006

JCI table of contents: August 1, 2006

A new study published in the Journal of Clinical Investigation found that marijuana use at conception and early pregnancy can prevent embryos from safely passing to the uterus, leading to early pregnancy failure. The study also showed that THC, a psychoactive component of marijuana, can swamp normal signaling systems, causing implantat...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 1, 2006

Marijuana use causes early pregnancy failure

A new study in mice reveals that marijuana use at conception and early pregnancy can cause embryos to fail to reach the uterus, resulting in early pregnancy failure. The study found that THC, a major psychoactive component of marijuana, disrupts anandamide signaling, leading to impaired fertility and ectopic pregnancies.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 1, 2006

JCI table of contents: July 27, 2006

Researchers found that glucocorticoids (GCs) alter the activity of bone-forming and bone-degrading cells, leading to delayed bone formation and resulting in GC-induced osteoporosis. Antisense oligonucleotides can be delivered through cerebrospinal fluid to treat neurodegenerative diseases like ALS.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 27, 2006

JCI table of contents: July 20, 2006

Research reveals that nicotine stimulates cell proliferation in lung cancer cells by activating the Rb–Raf-1 pathway, which is dependent on functional nicotinic acetylcholine receptors. Additionally, targeting tumor-associated macrophages holds promise as a novel strategy against breast and other cancers.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 20, 2006

JCI Table of Contents: July 13, 3006

Australian researchers identified a new protein in human airway epithelial cells that regulates allergic airway inflammation. A study suggests the protein aP2 plays an essential role in both type 2 diabetes and allergic airway diseases like asthma.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 13, 2006

Protein potentially links diet, obesity and asthma

The study reveals that protein aP2 is present in human epithelial cells lining the airways and its expression is increased by interleukin-4 and -13. Mice lacking aP2 exhibit reduced airway inflammation, highlighting the importance of lipids in inflammation and metabolism.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 13, 2006

JCI table of contents: July 3, 2006

Researchers found that Terry's brain underwent axonal re-growth, allowing for basic motor function and speech recovery. The study suggests a method to monitor brain function and track potential recovery in severely brain-damaged patients.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 3, 2006

JCI table of contents: June 22, 2006

Researchers develop a novel cancer vaccine delivery system using genetically modified Salmonella typhimurium that safely delivers antigens to the immune system, eliciting an immune response against cancer cells. Meanwhile, a DNA-based vaccine targeting tumor-associated fibroblasts significantly suppresses tumor growth and increases che...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 22, 2006

JCI Table of Contents, June 15 2006

Researchers found that AMP production is triggered by sterile wounding of the skin surface, independent of microbial exposure. The study also showed that activation of EGFR leads to increased antibacterial activity against Staphylococcus aureus and prevents microbial growth in human skin.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 15, 2006

JCI table of contents, June 8, 2006

A study found that HtrA1 protein contributes to chemotherapy resistance in ovarian and gastric cancers by inducing cell death, while ghrelin hormone promotes the storage of energy as fat by altering gene expression in adipose cells. The findings suggest potential therapeutic targets for obesity treatment.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 8, 2006

JCI table of contents, June 1, 2006

Researchers investigate the effects of hypoglycemia on insulin therapy in type 1 diabetes and discover a potential solution using urocortin I. Urocortin I suppresses the counterregulatory response to low blood sugar, impairing glucose-sensing neurons in the brain.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 1, 2006

A non-invasive method for measuring beta cell mass during diabetes

Researchers have developed a non-invasive method to measure beta cell mass in individuals with diabetes using PET-based quantitation of VMAT2 receptors. This approach allows for the estimation of beta cell mass in rats with type 1 diabetes, providing insights into the pathogenesis of diabetes and potential therapeutic interventions.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMay 18, 2006